A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.

The creatinine-to-cystatin C ratio may indicate the risk of developing amyotrophic lateral sclerosis, a large-scale database ...

News stories about clinical trials testing potential treatments were among the top 10 most-read articles on ALS News Today in ...

Despite the lower ALS risk, heart and metabolism problems are tied to faster disease progression and worse survival in the ...

This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other ...

As ALS progresses, annual healthcare costs for U.S. patients increase from an average of $31,000 to over $120,000, a Biogen ...

Columnist Kristin Neva is applying something she learned about finding moments to appreciate during winter to life with ALS.

When Dagmar Munn was diagnosed with ALS at the age of 59 in 2010, she tapped into her nearly 30 years of professional health and wellness experience. She not only follows her own advice but also ...

Juliet lost her husband, Jeff, to ALS in 2020, 19 months after his diagnosis. Together Jeff and Juliet enjoyed being on the water, live music, pets, and traveling. She was his primary caregiver, and ...

Columnist Kristin Neva shares family memories of when her husband, Todd, had just been diagnosed when he took their son on his first ride.